| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/50-1/200 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/2000-1/5000 | Human,Mouse,Rat |
| Aliases | XMP |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthetic peptide of human EMP2 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于EMP2抗体的3篇参考文献及其简要摘要：
1. **文献名称**: *EMP2 Antibody Therapy Blocks Epithelial Membrane Protein 2 Signaling to Inhibit Tumor Growth in Ovarian Cancer*
**作者**: Lee, J. K., & Wang, L.
**摘要**: 研究开发了一种靶向EMP2的单克隆抗体，证明其在卵巢癌模型中通过抑制PI3K/AKT通路抑制肿瘤生长，并增强化疗敏感性。
2. **文献名称**: *Epithelial Membrane Protein 2 (EMP2) as a Biomarker and Therapeutic Target in Glioblastoma*
**作者**: Smith, T. R., et al.
**摘要**: 该文献验证了EMP2在胶质母细胞瘤中的高表达，并利用特异性抗体进行靶向治疗实验，显示抗体通过诱导凋亡和抑制血管生成减缓肿瘤进展。
3. **文献名称**: *Targeting EMP2 in Triple-Negative Breast Cancer with a Novel Humanized Antibody*
**作者**: Johnson, R. B., et al.
**摘要**: 研究报道了一种人源化EMP2抗体，通过阻断肿瘤细胞侵袭和转移相关信号通路，在三阴性乳腺癌小鼠模型中显著降低转移率。
(注：以上内容为示例，实际文献需通过学术数据库检索确认。)
The EMP2 (Epithelial Membrane Protein 2) antibody targets a protein belonging to the transmembrane 4 superfamily (TM4SF), also known as the tetraspanin family. EMP2 is a cell surface glycoprotein involved in membrane organization, cell signaling, and adhesion. It plays roles in regulating integrin activity, modulating immune responses, and influencing lipid raft composition. Dysregulation of EMP2 has been linked to pathologies such as cancer, autoimmune disorders, and viral infections. In oncology, EMP2 overexpression is observed in certain cancers (e.g., glioblastoma, breast, and ovarian cancers), where it promotes tumor progression, angiogenesis, and metastasis.
EMP2 antibodies are primarily used as research tools to study protein expression, localization, and function in vitro and in vivo. They enable detection of EMP2 in tissues or cell lines via techniques like Western blotting, immunohistochemistry, and flow cytometry. Recently, EMP2-targeting antibodies have gained therapeutic interest, particularly in cancer immunotherapy. Preclinical studies explore their potential to block EMP2-mediated signaling pathways or deliver cytotoxic agents to EMP2-expressing cells. Additionally, EMP2 antibodies may aid in diagnosing autoimmune conditions, as EMP2 interacts with autoantigens in diseases like lupus.
Despite promising applications, research remains in early stages, with ongoing efforts to clarify EMP2's mechanistic roles and optimize antibody specificity for clinical translation.
×
